VBI Vaccines Appoints Blaine McKee to Board of Directors CAMBRIDGE, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...

Quick Cash Generation and Speed Are What Make Mergers with Troubled Companies Work—and Can Lead to Greater Rewards About 40% of Big-Company Mergers Require a Turnaround; Risks are Big, but Rewards Can be Greater, According to BCG TURN Report That Brings to Life Eight Successes BOSTON, Nov. 19, 2018 (GLOBE...

VBI Vaccines Appoints Christopher McNulty as Chief Financial Officer and Head of Business Development CAMBRIDGE, Mass., Aug. 15, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company, today announced the appointment of Christopher McNulty as...

MIT Enterprise Forum of Cambridge Presents a Keynote Address by Chris Viehbacher, CEO of Sanofi-aventis CAMBRIDGE, MA--(Marketwire - April 6, 2011) - On April 11, the MIT Enterprise Forum of Cambridge will feature a keynote by Chris Viehbacher, CEO of Sanofi-aventis. Headquartered in Paris, France,...